PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats. The company offers Rx pet medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; and OTC medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars.
Read More…
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryN/A
SectorMedical
Phone208-939-8900
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$528.61 million
Profitability
Miscellaneous
Employees1,452
Next Earnings Date3/9/2020 (Estimated)
OptionableOptionable
PetIQ (NASDAQ:PETQ) Frequently Asked Questions
What is PetIQ's stock symbol?
PetIQ trades on the NASDAQ under the ticker symbol "PETQ."
How were PetIQ's earnings last quarter?
PetIQ Inc (NASDAQ:PETQ) posted its quarterly earnings results on Wednesday, August, 7th. The company reported $0.70 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.35 by $0.35. The firm had revenue of $220.60 million for the quarter, compared to analyst estimates of $193.89 million. PetIQ had a positive return on equity of 9.77% and a negative net margin of 0.59%. The business's quarterly revenue was up 28.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.66 EPS. View PetIQ's Earnings History.
When is PetIQ's next earnings date?
What guidance has PetIQ issued on next quarter's earnings?
PetIQ issued an update on its FY 2019
After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $$680 million, compared to the consensus revenue estimate of $$684.5 million.
What price target have analysts set for PETQ?
2 brokers have issued 1-year price objectives for PetIQ's stock. Their forecasts range from $35.00 to $39.00. On average, they expect PetIQ's share price to reach $37.00 in the next year. This suggests a possible upside of 6.4% from the stock's current price. View Analyst Price Targets for PetIQ.
What is the consensus analysts' recommendation for PetIQ?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for PetIQ.
Has PetIQ been receiving favorable news coverage?
News articles about PETQ stock have trended very negative recently, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. PetIQ earned a coverage optimism score of -3.4 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for PetIQ.
Are investors shorting PetIQ?
PetIQ saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 4,070,000 shares, an increase of 8.8% from the January 15th total of 3,740,000 shares. Based on an average daily trading volume, of 386,200 shares, the days-to-cover ratio is currently 10.5 days. Approximately 19.1% of the company's stock are short sold. View PetIQ's Current Options Chain.
Who are some of PetIQ's key competitors?
What other stocks do shareholders of PetIQ own?
Who are PetIQ's key executives?
PetIQ's management team includes the folowing people:
- Mr. McCord Christensen, Chairman & CEO (Age 47)
- Ms. Susan Sholtis, Pres (Age 53)
- Mr. John Newland, Chief Financial Officer (Age 55)
- Mr. Robert Michael Herrman, Gen. Counsel & Sec.
- Mr. Adam Fellers, Sr. VP of Sales
When did PetIQ IPO?
(PETQ) raised $86 million in an initial public offering (IPO) on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.
Who are PetIQ's major shareholders?
PetIQ's stock is owned by many different of retail and institutional investors. Top institutional investors include Fred Alger Management LLC (10.52%), Janus Henderson Group PLC (3.40%), Russell Investments Group Ltd. (2.92%), Prentice Capital Management LP (2.78%), Peregrine Capital Management LLC (2.59%) and State Street Corp (1.63%). Company insiders that own PetIQ stock include Ecp Helios Partners Iv, LP, James Nathan Clarke, John Newland, Mccord Christensen, Ronald Kennedy, Susan Sholtis and Will Santana. View Institutional Ownership Trends for PetIQ.
Which major investors are selling PetIQ stock?
PETQ stock was sold by a variety of institutional investors in the last quarter, including Fred Alger Management LLC, PNC Financial Services Group Inc., Renaissance Technologies LLC, Royce & Associates LP, Raymond James & Associates, Sei Investments Co., Blair William & Co. IL and Bank of America Corp DE. Company insiders that have sold PetIQ company stock in the last year include Susan Sholtis and Will Santana. View Insider Buying and Selling for PetIQ.
Which major investors are buying PetIQ stock?
PETQ stock was purchased by a variety of institutional investors in the last quarter, including Prentice Capital Management LP, Russell Investments Group Ltd., Goldman Sachs Group Inc., Penn Capital Management Co. Inc., Peregrine Capital Management LLC, Boston Partners, AMI Asset Management Corp and Gabelli Funds LLC. Company insiders that have bought PetIQ stock in the last two years include James Nathan Clarke, John Newland and Ronald Kennedy. View Insider Buying and Selling for PetIQ.
How do I buy shares of PetIQ?
Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is PetIQ's stock price today?
One share of PETQ stock can currently be purchased for approximately $34.76.
How big of a company is PetIQ?
PetIQ has a market capitalization of $982.67 million and generates $528.61 million in revenue each year. The company earns $-780,000.00 in net income (profit) each year or $1.25 on an earnings per share basis. PetIQ employs 1,452 workers across the globe.View Additional Information About PetIQ.
What is PetIQ's official website?
How can I contact PetIQ?
PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]
MarketBeat Community Rating for PetIQ (NASDAQ PETQ)
MarketBeat's community ratings are surveys of what our community members think about PetIQ and other stocks. Vote "Outperform" if you believe PETQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
